Investigating natural antibiofilm components: a new therapeutic perspective against candidal vulvovaginitis.

[1]  F. Al-Misned,et al.  FbD directed fabrication and investigation of luliconazole based SLN gel for the amelioration of candidal vulvovaginitis: a 2 T (thermosensitive & transvaginal) approach , 2020, Saudi journal of biological sciences.

[2]  S. Talegaonkar,et al.  Design and in vitro/in vivo evaluations of a multiple-drug-containing gingiva disc for periodontotherapy , 2020, RSC advances.

[3]  M. Yasir,et al.  Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery , 2020, Advanced pharmaceutical bulletin.

[4]  Harpreet Singh,et al.  Chemistry and Pharmacology of Luliconazole (Imidazole Derivative): A Novel Bioactive Compound to Treat Fungal Infection-A Mini Review , 2020 .

[5]  M. Kaur,et al.  Luliconazole vesicular based gel formulations for its enhanced topical delivery , 2020, Journal of liposome research.

[6]  M. A. Mirza,et al.  A 4-D approach for amelioration of periodontitis. , 2019, Medical hypotheses.

[7]  Z. Iqbal,et al.  Molecular Docking-Guided Ungual Drug-Delivery Design for Amelioration of Onychomycosis , 2019, ACS omega.

[8]  Z. Iqbal,et al.  Nanocarriers for vaginal drug delivery. , 2019, Recent patents on drug delivery & formulation.

[9]  M. Rouabhia,et al.  The Effects of Mentha × piperita Essential Oil on C. albicans Growth, Transition, Biofilm Formation, and the Expression of Secreted Aspartyl Proteinases Genes , 2019, Antibiotics.

[10]  Brendan R. Jackson,et al.  Estimation of Direct Healthcare Costs of Fungal Diseases in the United States. , 2018, Clinical Infectious Diseases.

[11]  P. Dehghan,et al.  In vitro Activity of New Azole Luliconazole Compared to Fluconazole against Candida Strains Isolated from Oral Lesions of Cancer Patients , 2019 .

[12]  S. Mohammadi-Samani,et al.  Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages , 2018, Research in pharmaceutical sciences.

[13]  R. Saha,et al.  Nanostructured lipid carriers for site-specific drug delivery. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  Miguel C. Teixeira,et al.  Candida Biofilms: Threats, Challenges, and Promising Strategies , 2018, Front. Med..

[15]  A. Zarei Mahmoudabadi,et al.  Luliconazole, a new antifungal against Candida species isolated from different sources. , 2017, Journal de mycologie medicale.

[16]  K. Lagrou,et al.  Candida and its dual lifestyle as a commensal and a pathogen. , 2017, Research in microbiology.

[17]  N. Škalko-Basnet,et al.  Lipid-Based Nanopharmaceuticals in Antimicrobial Therapy , 2017 .

[18]  M. Henriques,et al.  Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors , 2016, Critical reviews in microbiology.

[19]  C. Nakamura,et al.  Antimicrobial effects of Piper hispidum extract, fractions and chalcones against Candida albicans and Staphylococcus aureus. , 2016, Journal de mycologie medicale.

[20]  M. Chorilli,et al.  Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment , 2016, International journal of molecular sciences.

[21]  Shweta Singh,et al.  Citronellal-induced disruption of membrane homeostasis in Candida albicans and attenuation of its virulence attributes. , 2016, Revista da Sociedade Brasileira de Medicina Tropical.

[22]  C. Nobile,et al.  Candida albicans biofilms: development, regulation, and molecular mechanisms. , 2016, Microbes and infection.

[23]  S. Talegaonkar,et al.  A vaginal drug delivery model , 2016, Drug delivery.

[24]  Shweta Singh,et al.  Insights into the mode of action of anticandidal herbal monoterpenoid geraniol reveal disruption of multiple MDR mechanisms and virulence attributes in Candida albicans , 2016, Archives of Microbiology.

[25]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Kanwar,et al.  Exploration of the anticandidal mechanism of Cassia spectabilis in debilitating candidiasis , 2015, Journal of traditional and complementary medicine.

[27]  V. Préat,et al.  Nanostructured lipid carriers: Promising drug delivery systems for future clinics. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[28]  J. Sobel.  Recurrent vulvovaginal candidiasis. , 1987, American journal of obstetrics and gynecology.

[29]  Jing Xu,et al.  Sesquiterpenes from Carpesium macrocephalum inhibit Candida albicans biofilm formation and dimorphism. , 2015, Bioorganic & medicinal chemistry letters.

[30]  Alexander D. Johnson,et al.  Candida albicans Biofilms and Human Disease. , 2015, Annual review of microbiology.

[31]  J. Martinez-de-Oliveira,et al.  Studies and methodologies on vaginal drug permeation. , 2015, Advanced drug delivery reviews.

[32]  A. Isla,et al.  Vaginal gene therapy. , 2015, Advanced drug delivery reviews.

[33]  Giuseppina Sandri,et al.  Mucoadhesive and thermogelling systems for vaginal drug delivery. , 2015, Advanced drug delivery reviews.

[34]  J. Sudji,et al.  Alternative treatment of vaginal infections – in vitro antimicrobial and toxic effects of Coriandrum sativum L. and Thymus vulgaris L. essential oils , 2015, Journal of applied microbiology.

[35]  S. Ha,et al.  Current and Recent Advanced Strategies for Combating Biofilms , 2015 .

[36]  A. Cassone,et al.  Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects , 2015, BJOG : an international journal of obstetrics and gynaecology.

[37]  J. Schwebke,et al.  Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  Jiru Xu,et al.  Fresh Garlic Extract Enhances the Antimicrobial Activities of Antibiotics on Resistant Strains in Vitro , 2015, Jundishapur journal of microbiology.

[39]  Erika Shor,et al.  Update on Antifungal Drug Resistance , 2015, Current Clinical Microbiology Reports.

[40]  Yue Zheng,et al.  Biofilm formation mechanisms and targets for developing antibiofilm agents. , 2015, Future medicinal chemistry.

[41]  J. Arias,et al.  Nano-sized platforms for vaginal drug delivery. , 2015, Current pharmaceutical design.

[42]  D. S. Arora,et al.  Antibiofilm potential of flavonoids extracted from Moringa oleifera seed coat against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans , 2015, Journal of applied microbiology.

[43]  V. Kadam,et al.  SOLID LIPID NANOPARTICLES BASED GEL FOR TOPICAL DELIVERY OF ANTIFUNGAL AGENT , 2015 .

[44]  D. Arko,et al.  Treatment of vulvovaginal candidiasis: a review of the literature. , 2015, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[45]  S. Cannas,et al.  Antifungal, anti-biofilm and adhesion activity of the essential oil of Myrtus communis L. against Candida species , 2014, Natural product research.

[46]  A. Sartoratto,et al.  Coriandrum sativum L. (Coriander) Essential Oil: Antifungal Activity and Mode of Action on Candida spp., and Molecular Targets Affected in Human Whole-Genome Expression , 2014, PloS one.

[47]  M. S. Khan,et al.  Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans. , 2012, Journal of ethnopharmacology.

[48]  L. Rohan,et al.  The importance of the vaginal delivery route for antiretrovirals in HIV prevention. , 2011, Therapeutic delivery.

[49]  J. F. Höfling,et al.  Action of Coriandrum sativum L. Essential Oil upon Oral Candida albicans Biofilm Formation , 2011, Evidence-based complementary and alternative medicine : eCAM.

[50]  G. Coruzzi,et al.  Mesotherapy versus Systemic Therapy in the Treatment of Acute Low Back Pain: A Randomized Trial , 2010, Evidence-based complementary and alternative medicine : eCAM.

[51]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  Des Spence.  Candidiasis (vulvovaginal). , 2007, BMJ clinical evidence.

[53]  H. Yamaguchi,et al.  In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses , 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[54]  M. Owais,et al.  Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis , 2005, Journal of drug targeting.

[55]  Robin Patel,et al.  Effects of Fresh Garlic Extract on Candida albicans Biofilms , 2005, Antimicrobial Agents and Chemotherapy.

[56]  P. Hay.  Bacterial Vaginosis as a Mixed Infection , 2002 .